In GBS patients, parts of the body suddenly become numb, muscle weakness develops, and they may also face difficulty in ...
After GBS outbreak in Madhya Pradesh’s Neemuch district, doctors explain how the immunological disorder presents in children, ...
At least two people died after a Guillain-Barré Syndrome outbreak in Madhya Pradesh's Neemuch district. So far 14 patients ...
(Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today ...
GBS is a disease in which a patient’s immune system mistakenly starts attacking the peripheral nervous system. The disease is ...
GBS outbreak in Madhya Pradesh claims two lives; authorities enhance detection and treatment measures to address the crisis.
Annexon, Inc. (ANNX) was able to achieve positive results from its phase 3 study for the treatment of patients with Guillain-Barré syndrome [GBS]. Matter of fact, it noted that a lower dose of its ...
LUND, Sweden, Dec. 17, 2024 /PRNewswire/ -- Hansa Biopharma, "Hansa" (Nasdaq Stockholm: HNSA), today announced positive full results from the 15-HMedIdeS-09 single arm Phase 2 study of imlifidase, a ...
An outbreak of Guillain-Barré Syndrome in Neemuch, Madhya Pradesh has resulted in two deaths. Authorities are setting up ...
State government includes costly GBS therapy in Ayushman Bharat–Arogya Karnataka scheme, offering financial support to affected patients.
Two deaths and 14 cases of Guillain-Barré Syndrome reported in Neemuch, Madhya Pradesh. State ramps up detection, treatment, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback